Osteoporosis Treatment -- Identifying the Wrong Statement
Drugs for osteoporosis classified by mechanism:
- Antiresorptive (reduce bone loss): Bisphosphonates, Denosumab, SERMs (Raloxifene), Calcitonin
- Anabolic (build bone): Teriparatide (PTH 1-34), Abaloparatide, Romosozumab
Correct treatment sequence:
1. Calcium 1200 mg/day + Vitamin D3 (baseline for all patients)
2. Bisphosphonates (first-line antiresorptive): given for 3-5 years then drug holiday considered
3. Teriparatide: reserved for severe osteoporosis, multiple fractures, or bisphosphonate failure -- ALWAYS after, not before, bisphosphonates
Why Option A is WRONG:
Prior bisphosphonate use actually reduces the anabolic efficacy of teriparatide. The correct practice is: give bisphosphonates first; if still at high fracture risk, switch to teriparatide. Starting teriparatide before bisphosphonates has no evidence base and reverses the recommended sequence.
Colles fracture in a 60-year-old female = fragility fracture = osteoporosis diagnosis confirmed clinically even without DEXA.
\[\boxed{\text{Option A: Teriparatide before bisphosphonates (WRONG statement)}}\]